22 results
8-K
EX-99.1
cuofnosnx90t
12 Aug 21
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
10:41am
10-K
h668mxo
16 Mar 21
Annual report
8:20am
424B4
pwt8akveaw67v1sp35
7 Jan 21
Prospectus supplement with pricing info
4:11pm
DRS
ubah1djj05ynpd
21 Dec 20
Draft registration statement
12:00am
10-Q
ykb3 elxknt812xa
10 Nov 20
Quarterly report
8:00am
424B4
cvuodlhka ys1bj
25 Sep 20
Prospectus supplement with pricing info
4:08pm
S-1
ll77m skfny8
4 Sep 20
IPO registration
4:48pm